185 related articles for article (PubMed ID: 29878346)
21. WNT signalling: mechanisms and therapeutic opportunities.
Schulte G; Bryja V
Br J Pharmacol; 2017 Dec; 174(24):4543-4546. PubMed ID: 29235106
[TBL] [Abstract][Full Text] [Related]
22. Photolabeling a Nicotinic Acetylcholine Receptor (nAChR) with an (α4)3(β2)2 nAChR-Selective Positive Allosteric Modulator.
Hamouda AK; Deba F; Wang ZJ; Cohen JB
Mol Pharmacol; 2016 May; 89(5):575-84. PubMed ID: 26976945
[TBL] [Abstract][Full Text] [Related]
23. Stable expression and functional characterization of a human nicotinic acetylcholine receptor with α6β2 properties: discovery of selective antagonists.
Capelli AM; Castelletti L; Chen YH; Van der Keyl H; Pucci L; Oliosi B; Salvagno C; Bertani B; Gotti C; Powell A; Mugnaini M
Br J Pharmacol; 2011 May; 163(2):313-29. PubMed ID: 21232042
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of nicotinic acetylcholine receptors by bicuculline.
Demuro A; Palma E; Eusebi F; Miledi R
Neuropharmacology; 2001 Dec; 41(7):854-61. PubMed ID: 11684149
[TBL] [Abstract][Full Text] [Related]
25. Rat neuronal nicotinic acetylcholine receptors containing alpha7 subunit: pharmacological properties of ligand binding and function.
Xiao Y; Abdrakhmanova GR; Baydyuk M; Hernandez S; Kellar KJ
Acta Pharmacol Sin; 2009 Jun; 30(6):842-50. PubMed ID: 19448648
[TBL] [Abstract][Full Text] [Related]
26. Physical and virtual screening methods for marine toxins and drug discovery targeting nicotinic acetylcholine receptors.
Molgó J; Aráoz R; Benoit E; Iorga BI
Expert Opin Drug Discov; 2013 Oct; 8(10):1203-23. PubMed ID: 23919818
[TBL] [Abstract][Full Text] [Related]
27. α7-Containing and non-α7-containing nicotinic receptors respond differently to spillover of acetylcholine.
Stanchev D; Sargent PB
J Neurosci; 2011 Oct; 31(42):14920-30. PubMed ID: 22016525
[TBL] [Abstract][Full Text] [Related]
28. When pharmacology meets the microbiome: new targets for therapeutics?
Hyland NP; Cryan JF
Br J Pharmacol; 2018 Dec; 175(24):4401-4403. PubMed ID: 30478976
[TBL] [Abstract][Full Text] [Related]
29. Recent developments in research of melatonin and its potential therapeutic applications.
Stanford SC
Br J Pharmacol; 2018 Aug; 175(16):3187-3189. PubMed ID: 30917240
[TBL] [Abstract][Full Text] [Related]
30. Molecular determinants of α-conotoxin potency for inhibition of human and rat α6β4 nicotinic acetylcholine receptors.
Hone AJ; Talley TT; Bobango J; Huidobro Melo C; Hararah F; Gajewiak J; Christensen S; Harvey PJ; Craik DJ; McIntosh JM
J Biol Chem; 2018 Nov; 293(46):17838-17852. PubMed ID: 30249616
[TBL] [Abstract][Full Text] [Related]
31. Synaptic potentials mediated by alpha 7 nicotinic acetylcholine receptors in supraoptic nucleus.
Hatton GI; Yang QZ
J Neurosci; 2002 Jan; 22(1):29-37. PubMed ID: 11756485
[TBL] [Abstract][Full Text] [Related]
32. Alpha-conotoxin AuIB isomers exhibit distinct inhibitory mechanisms and differential sensitivity to stoichiometry of alpha3beta4 nicotinic acetylcholine receptors.
Grishin AA; Wang CI; Muttenthaler M; Alewood PF; Lewis RJ; Adams DJ
J Biol Chem; 2010 Jul; 285(29):22254-63. PubMed ID: 20466726
[TBL] [Abstract][Full Text] [Related]
33. Non-competitive Inhibition of Nicotinic Acetylcholine Receptors by Ladybird Beetle Alkaloids.
Leong RL; Xing H; Braekman JC; Kem WR
Neurochem Res; 2015 Oct; 40(10):2078-86. PubMed ID: 25370792
[TBL] [Abstract][Full Text] [Related]
34. Combined actions of zinc and fluoxetine on nicotinic acetylcholine receptors.
García-Colunga J; Vázquez-Gómez E; Miledi R
Pharmacogenomics J; 2004; 4(6):388-93. PubMed ID: 15354177
[TBL] [Abstract][Full Text] [Related]
35. Unorthodox Acetylcholine Binding Sites Formed by α5 and β3 Accessory Subunits in α4β2* Nicotinic Acetylcholine Receptors.
Jain A; Kuryatov A; Wang J; Kamenecka TM; Lindstrom J
J Biol Chem; 2016 Nov; 291(45):23452-23463. PubMed ID: 27645992
[TBL] [Abstract][Full Text] [Related]
36. α-Conotoxin VnIB from Conus ventricosus is a potent and selective antagonist of α6β4* nicotinic acetylcholine receptors.
van Hout M; Valdes A; Christensen SB; Tran PT; Watkins M; Gajewiak J; Jensen AA; Olivera BM; McIntosh JM
Neuropharmacology; 2019 Oct; 157():107691. PubMed ID: 31255696
[TBL] [Abstract][Full Text] [Related]
37. α-Conotoxins to explore the molecular, physiological and pathophysiological functions of neuronal nicotinic acetylcholine receptors.
Giribaldi J; Dutertre S
Neurosci Lett; 2018 Jul; 679():24-34. PubMed ID: 29199094
[TBL] [Abstract][Full Text] [Related]
38. Analogs of methyllycaconitine as novel noncompetitive inhibitors of nicotinic receptors: pharmacological characterization, computational modeling, and pharmacophore development.
McKay DB; Chang C; González-Cestari TF; McKay SB; El-Hajj RA; Bryant DL; Zhu MX; Swaan PW; Arason KM; Pulipaka AB; Orac CM; Bergmeier SC
Mol Pharmacol; 2007 May; 71(5):1288-97. PubMed ID: 17308033
[TBL] [Abstract][Full Text] [Related]
39. Selective deletion of the alpha5 subunit differentially affects somatic-dendritic versus axonally targeted nicotinic ACh receptors in mouse.
Fischer H; Orr-Urtreger A; Role LW; Huck S
J Physiol; 2005 Feb; 563(Pt 1):119-37. PubMed ID: 15611037
[TBL] [Abstract][Full Text] [Related]
40. Design and synthesis of α-conotoxin GID analogues as selective α4β2 nicotinic acetylcholine receptor antagonists.
Banerjee J; Yongye AB; Chang YP; Gyanda R; Medina-Franco JL; Armishaw CJ
Biopolymers; 2014 Jan; 102(1):78-87. PubMed ID: 24122487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
